Skip to content

Clinical trials

Completed Digestive System Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Digestive System Neoplasms Status: Completed Country / region: China Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20141
20162
20173
20181
20191
20203
20212
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Creative Biosciences (Guangzhou) Co., Ltd.2
Jinling Hospital, China2
Sumitomo Pharma America, Inc.2
Zhejiang University2
Eastern Hepatobiliary Surgery Hospital1
Fudan University1
Hoffmann-La Roche1
Imunon1
Novartis Pharmaceuticals1
Peking University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Digestive System Neoplasms18
Neoplasms9
Digestive System Diseases7
Colorectal Neoplasms6
Gastrointestinal Neoplasms6
Neoplasms by Site6
Neoplasms by Histologic Type5
Adenocarcinoma4
Carcinoma, Hepatocellular4
Colonic Diseases4

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.